On 7th and 8th March took place the 5th edition of Farmaforum. Farmaforum is an event that has grown steadily year on year and became one of the most important in the pharmaceutical industry in Spain.
Sandra Villagrasa, Labiana Pharmaceuticals Deputy General Director , had the honour to participate as a guest speaker to the panel discussion on serialization. Here, she had the opportunity to share the approach of a pharmaceutical manufacturing laboratory to the implementation of the Commission Delegated Regulation 2016/161/EU (Falsified Medicine Directive FMD 2011/62/EU). The regulation establishes the requirement to implement serialization before February 9th, 2019 for the whole pharmaceutical industry of the EU-member states.
The panel discussion titled “360º Serialization“, moderated by Eugeni Sedano, Institutional Support Liaison at Esteve and Ordinary Member of Board of the Official Pharmacists Colleges of Spain, consisted of a panel of experts formed by all the pharmaceutical supply chain.
Sandra Villagrasa explained the phases of the implementation project, the milestones and challenges faced by the manufacturing laboratories. She featured the large investment in term of economic, technological and management resources required to address such an important anti-counterfeiting regulation. Among the speakers were Javier Rodríguez-Carmona, Technology Director of the Spanish Medicines Verification Organisation (Sevem); Juan Jorge Poveda, Head of the Office of the Director of COFARES and Ordinary Member of Board of the Official Pharmacists Colleges of Madrid; Ana Herranz, Ordinary Member of the Hospital Pharmacy section of the General Council of Official Pharmaceutical College; Teodomiro Hidalgo, Ordinary Member of the Pharmacies section the Official Pharmacists Colleges of Spain and Ariel Romero Diaz, EMEA & US Regional Sales Manager at Verifarma.
The 5th edition of Farmaforum, inaugurated by Belén Crespo, Director of the Spanish Agency for Medicines and Health Products, was attended by high-level experts who discussed the most recent issues, such as data integrity and harmonization, Industry 4.0, Serialization, APIs processing, the Pharmaceutical Supply Chain Initiative and other topics related to human resources, GMP audits and UE-US harmonization process.
Farmaforum has undoubtedly been a unique opportunity to share our experience with different entities of the sector and to learn how various actors from the supply chain deal with an implementation which guarantees the fulfilment of the European Directive.